Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
2000 3
2001 1
2003 3
2004 2
2006 6
2007 8
2008 8
2009 14
2010 12
2011 19
2012 22
2013 13
2014 10
2015 6
2016 7
2017 6
2018 1
2019 4
2020 6
2021 6
2022 5
2023 1
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Drospirenone/ethinyl estradiol.
Rapkin AJ, Sorger SN, Winer SA. Rapkin AJ, et al. Drugs Today (Barc). 2008 Feb;44(2):133-45. doi: 10.1358/dot.2008.44.2.1191057. Drugs Today (Barc). 2008. PMID: 18389090 Review.
Drospirenone 3 mg/ethinyl estradiol 20 microg (24/4) is a new unique oral contraceptive formulation that combines in a novel dosing regimen the lowest dosage of ethinyl estradiol commonly used today with drospirenone, an innovative progestin. ...The prolongation of …
Drospirenone 3 mg/ethinyl estradiol 20 microg (24/4) is a new unique oral contraceptive formulation that combines in a novel dosing r …
Combined oral contraceptives: venous thrombosis.
de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. de Bastos M, et al. Cochrane Database Syst Rev. 2014 Mar 3;2014(3):CD010813. doi: 10.1002/14651858.CD010813.pub2. Cochrane Database Syst Rev. 2014. PMID: 24590565 Free PMC article. Review.
The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparisons. Unadjusted relative risks with 95% confidence intervals were reported.Two independent reviewers extracted data from selected studies. . …
The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparis …
Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results.
Creinin MD, Westhoff CL, Bouchard C, Chen MJ, Jensen JT, Kaunitz AM, Achilles SL, Foidart JM, Archer DF. Creinin MD, et al. Contraception. 2021 Sep;104(3):222-228. doi: 10.1016/j.contraception.2021.05.002. Epub 2021 May 15. Contraception. 2021. PMID: 34000251 Free article. Clinical Trial.
CONCLUSION: E4/DRSP is an effective oral contraceptive with a predictable bleeding pattern for most women and low AE rates. IMPLICATIONS STATEMENT: A new oral contraceptive with a novel estrogen, estetrol, combined with drospirenone has efficacy and safety within th …
CONCLUSION: E4/DRSP is an effective oral contraceptive with a predictable bleeding pattern for most women and low AE rates. IMPLICATI …
Comparison of estrogenic components used for hormonal contraception.
Stanczyk FZ, Winer SA, Foidart JM, Archer DF. Stanczyk FZ, et al. Contraception. 2024 Feb;130:110310. doi: 10.1016/j.contraception.2023.110310. Epub 2023 Oct 18. Contraception. 2024. PMID: 37863464 Review.
Recently, a COC incorporating a novel weak natural estrogen, estetrol (E(4)), combined with drospirenone, has become available. We present a comparative analysis of the three prevailing estrogens used in COCs, focusing on their structure-function relationships, receptor-bi …
Recently, a COC incorporating a novel weak natural estrogen, estetrol (E(4)), combined with drospirenone, has become available. We pr …
Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive.
Han L, Jensen JT. Han L, et al. Expert Opin Pharmacother. 2014 Oct;15(14):2071-9. doi: 10.1517/14656566.2014.949237. Epub 2014 Sep 4. Expert Opin Pharmacother. 2014. PMID: 25186109 Review.
INTRODUCTION: Oral contraceptives are often prescribed in extended or continuous forms in order to manage menstrual bleeding and menstrual-related side effects. However, with extended regimens, unscheduled intracycle bleeding can become problematic. Flexible extended dosin …
INTRODUCTION: Oral contraceptives are often prescribed in extended or continuous forms in order to manage menstrual bleeding and menstrual-r …
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.
Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Stegeman BH, et al. BMJ. 2013 Sep 12;347:f5298. doi: 10.1136/bmj.f5298. BMJ. 2013. PMID: 24030561 Free PMC article. Review.
The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparisons. Unadjusted relative risks with 95% confidence intervals were reported. ...The relative risk of venous thrombosis for combined oral cont …
The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparis …
The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs.
McAdams M, Staffa JA, Dal Pan GJ. McAdams M, et al. Contraception. 2007 Oct;76(4):278-81. doi: 10.1016/j.contraception.2007.06.002. Epub 2007 Aug 1. Contraception. 2007. PMID: 17900437
BACKGROUND: Ethinyl estradiol 0.03 mg/drospirenone 3 mg (EE/DRSP) contains a progestin drospirenone with antimineralocorticoid properties that may cause potassium retention leading to hyperkalemia. ...
BACKGROUND: Ethinyl estradiol 0.03 mg/drospirenone 3 mg (EE/DRSP) contains a progestin drospirenone with antimineralocorticoid …
Health Status Is Affected, and Phase I/II Biotransformation Activity Altered in Young Women Using Oral Contraceptives Containing Drospirenone/Ethinyl Estradiol.
Venter G, van der Berg CL, van der Westhuizen FH, Erasmus E. Venter G, et al. Int J Environ Res Public Health. 2021 Oct 10;18(20):10607. doi: 10.3390/ijerph182010607. Int J Environ Res Public Health. 2021. PMID: 34682353 Free PMC article. Clinical Trial.
Combined oral contraceptive (COC) use has been associated with various adverse effects. Formulations containing drospirenone (DRSP) and ethinyl estradiol (EE) are generally regarded as milder COCs. ...COCs containing DRSP/EE may, therefore, adversely affect h …
Combined oral contraceptive (COC) use has been associated with various adverse effects. Formulations containing drospirenon …
Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial.
Nisenbaum MG, de Melo NR, Giribela CR, de Morais TL, Guerra GM, de Angelis K, Mostarda C, Baracat EC, Consolim-Colombo FM. Nisenbaum MG, et al. Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:62-6. doi: 10.1016/j.ejogrb.2014.01.006. Epub 2014 Jan 13. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24480113 Free article. Clinical Trial.
OBJECTIVE: To evaluate the effect of a contraceptive containing 20mcg of ethinyl estradiol and 3mg of drospirenone on the heart rate variability, baroreflex sensitivity and blood pressure of healthy women. ...CONCLUSION: A contraceptive containing 20mcg of ethinyl estradio …
OBJECTIVE: To evaluate the effect of a contraceptive containing 20mcg of ethinyl estradiol and 3mg of drospirenone on the heart rate …
Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study.
Battaglia C, Morotti E, Persico N, Battaglia B, Busacchi P, Casadio P, Paradisi R, Venturoli S. Battaglia C, et al. J Sex Med. 2014 Feb;11(2):471-80. doi: 10.1111/jsm.12392. Epub 2013 Dec 2. J Sex Med. 2014. PMID: 24299553 Clinical Trial.
AIM: The aim of this study is to evaluate the genital vascular effects and sexual behavior of an OC containing 30 mug ethinyl estradiol and 3 mg drospirenone in comparison with a flexible combined contraceptive vaginal ring. ...
AIM: The aim of this study is to evaluate the genital vascular effects and sexual behavior of an OC containing 30 mug ethinyl estradi …
143 results